RN7SL1 and breast cancer: Mechanistically, we demonstrated that when stromal fibroblasts and basal-like breast cancer cells interact, fibroblast-derived exosomal RN7SL1 is not bound by its canonical RBPs and can act as a potent activator of RIG-I in recipient breast cancer cells.